Articles On Rhythm Biosciences (ASX:RHY)

Title Source Codes Date
Rhythm Biosciences establishes internationally renowned clinical advisory board

“We are honoured to have world-class, distinguished leaders in their field of Colorectal Cancer diagnostics form our CAB and look forward to their expertise and guidance in this significant commercialisation stage of ColoSTAT,” said...

BiotechDispatch RHY 1 week ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead RHY 1 month ago
Closing Bell: Markets up almost 0.1pc on Friday as the cows take control

  ASX200 rises by a broken fingernail and just looks flat IT gains offset by Energy losses as uranium stocks get hit hard Really peculiar bunch of small cap winners led by AVA Risk and Venture Minerals   Local markets have wavered either...

Stockhead RHY 1 month ago
Rhythm Biosciences flags positive data for lung cancer diagnostic test

Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer The company used a cohort of 70 healthy and cancerous patients It will now move towards a larger s...

themarketherald.com.au RHY 4 months ago
ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding

Rhythm Bio says biomarker findings warrant the case for new investment in R&D Dental focused SDI says product registration globally is becoming more difficult to achieve   Rhythm Bio says new R&D investment is warranted after this...

Stockhead RHY 4 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead RHY 4 months ago
ASX October winners: The 50 best ASX stocks as Israel-Hamas escalation adds further pressure to fragile markets

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Stockhead RHY 4 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead RHY 5 months ago
Traders’ Diary: A week of War, Worry and Wall Street earnings

The Week That Was The world looks very different this week after the addition of what Barclays economic team calls ‘a complex cocktail of geopolitical risk, mixed macro data, a nervous oil market,’ and a US Fed finding nice things to say ab...

Stockhead RHY 5 months ago
Closing Bell: Wall St loses bottle over rates; ASX spits dummy over said lost bottle; China stagnates (a bit less); USD crushes AUD

Benchmark ASX index closes -0.6% lower, but gains for the week ASX Sectors led by Utilities which jumped +5.0% since Monday Small caps led by HOR, FTZ, SWF   The ASX200 has closed lower on Friday, ending the session -0.6% lower, but ahe...

Stockhead RHY 5 months ago
Closing Bell: Stupid ASX loses confidence, ends flat… but 25pc of Redbubble’s back

Benchmark ASX index finishes ever so slightly up ASX Sectors led by Financial, IT, Property and Materials Small cap gainers: RBL, PIL, and LPI   Here’s how we ended on Thursday. Local markets largely did okay, and then wilted when we go...

Stockhead RHY 5 months ago
Top 10 at 11: Lithium, gold and old news are propelling the market this morning

Stockhead’s Top 10 at shortly-before-11-ish, produced approximately on time, and largely dependent on whether this god-awful NBN decides it’s “too hot outside” to function properly. Top 10 highlights the best (and sometimes worst) performin...

Stockhead RHY 5 months ago
Closing Bell: Local markets ignore the conflict, follow the money to a fifth day of wins

ASX 200 closes higher for a fifth straight day All 11 Sectors make it home for supper Small caps led by Zuleika and Creasy   It’s fair to say the little battler of an Aussie sharemarket’s put in a real decent day’s work. As various part...

Stockhead RHY 5 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead RHY 6 months ago
2 ASX healthcare shares racing higher on positive updates

The market may be falling for a fourth day in a row, but that hasn't stopped a couple of ASX healthcare shares from charging higher today. Here's what is getting investors excited about them on Wednesday: Race Oncology Ltd (ASX: RAC) The...

Motley Fool RHY 6 months ago
Rhythm Biosciences provides breast cancer diagnostic test update

Rhythm Biosciences (ASX:RHY) has provided an update on its cancer diagnostics technology platform expansion program in breast cancer.

BiotechDispatch RHY 6 months ago
ASX cancer stocks guide: Here’s everything you need to know

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

Stockhead RHY 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead RHY 6 months ago
In Case You Missed It: A consumer products divestment and a dash of lithium

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead RHY 6 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead RHY 6 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead RHY 6 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead RHY 7 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead RHY 7 months ago
Rhythm Biosciences looks ahead to market entry with launch of UK subsidiary

Cancer diagnostics technology company Rhythm Biosciences (ASX:RHY) says it has further progressed its market entry strategy for ColoSTAT in the UK by establishing a fully-owned subsidiary.

BiotechDispatch RHY 8 months ago
ASX Health Stocks: Lumos soars 327pc after US FDA approval for aid to detect bacterial respiratory infections

Lumos soars after US FDA approval for FebriDx rapid, point-of-care test Emyria will buy the Pax Centre for $1.7 million following psychedelic medicine law changes in Australia Rhythm Biosciences establishes UK subsidiary as part of strateg...

Stockhead RHY 8 months ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead RHY 9 months ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead RHY 9 months ago
ASX Director Trades: Universal Store Holdings directors buy up big, Kelsian sold down for charity

Advance ZinkTek chairman buys up $1.78 million worth of shares increasing his holding to more than 51% Youth apparel retailer Universal Holdings sees several of its directors bullish despite economic headwinds Kelsian Group non-executive d...

Stockhead RHY 9 months ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead RHY 9 months ago
Rhythm BioSciences (ASX: RHY) pens partnership with LINK Medical Solutions

Rhythm BioSciences (ASX:RHY) progresses its market entry of ColoSTAT into the United Kingdom, following UKCA mark certification The company penned a new partnership with London-based LINK Medical Solutions to assist with a phased approach...

themarketherald.com.au RHY 10 months ago
ASX falls 0.49% on second straight day of losses

ShareCafeASX falls 0.49% on second straight day of losses by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.49 per cent lower at 7,199.20. The ASX experienced a second consecutive day of decline, with major banks and mining c...

ShareCafe RHY 10 months ago
CLOSING BELL: Hump Day is Slump Day yet again, as the ASX drops another 0.46%

After a shaky start, the benchmark improved but still lost ground overall InfoTech did well to add 1.04%, but MAterials, Financials and Staples all weighed Standout winner was Rhythm Biosciences, up 88.6% on massive milestone news   Today...

Stockhead RHY 10 months ago
In Case You Missed It: Cancer fighters, Kalahari copper and corporate travel on the rise

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead RHY 10 months ago
TMH market close: Information Technology shines in a sea of red

The ASX 200 closed lower today, falling 0.49 per cent to close at 7199.2 points. It came after the Australian Bureau of Statistics revealed wage prices are still too high. In the green Information technology was the standout sector...

themarketherald.com.au RHY 10 months ago
Rhythm Biosciences (ASX:RHY) shares price doubles over UK approval for ColoSTAT

Rhythm Biosciences’ (RHY) share price more than doubles after securing regulatory approval for its colon cancer detection blood test in the UK The UKCA mark certification has been granted for ColoSTAT – an affordable and user-friendly bl...

themarketherald.com.au RHY 10 months ago
TMH Spotlight: Voltaic Strategic Resources (ASX:VSR) confirms rare earths system at Neo, Toubani Resources (ASX:TRE) unlocks new structure

The Wage Price Index (WPI) has lifted to its highest level in more than ten years. That’s according to the latest data from the Australian Bureau of Statistics (ABS). The index increased point-eight per cent in the March quarter of 2023,...

themarketherald.com.au RHY 10 months ago
Stocks of the Hour: Magnis Energy, QX Res, Rhythm Biosciences, Wildcat Res

17 May 2023 - A snapshot of the stocks on the move featuring Magnis Energy Technologies (ASX:MNS), QX Resources (ASX:QXR), Rhythm Biosciences (ASX:RHY) and Wildcat Resources (ASX:W…

FNN RHY 10 months ago
ASX All ords biotech stock explodes 120% on regulatory green light

The All Ordinaries Index (ASX: XAO) is down 0.42% in lunchtime trading, but this ASX All Ords biotech stock is bucking the trend. The Rhythm Biosciences Ltd (ASX: RHY) share price is rocketing 120% higher today to 77 cents. Let’s take a...

Motley Fool RHY 10 months ago
ASX down 0.51% at noon as Australian wages grow

ShareCafeASX down 0.51% at noon as Australian wages grow by Peter Milios   At noon, the S&P/ASX 200 is 0.51 per cent lower at 7,198.10, after initially dropping as much as 1 per cent at the opening. Meanwhile, in Wall Street trading, th...

ShareCafe RHY 10 months ago
Stocks of the Hour: MNS, QXR, RHY, WC8

ShareCafeStocks of the Hour: MNS, QXR, RHY, WC8                    Magnis Energy Technologies (ASX:MNS; OTCQX: MNSEF; FSE:U1P) has announced that their lithium ion cell manufacturer iM3NY has entered into a JV Agreement with OSM. iM3N...

ShareCafe RHY 10 months ago
Rhythm Biosciences receives UKCA mark for ColoSTAT colorectal blood test kit

This content is created by Smallcaps Authors. [Author : Imelda Cotton] A simple blood test used for the detection of colorectal cancer has achieved UK Conformity Assessed (UKCA) marking for developer Rhythm Biosciences (ASX: RHY). The reg...

SmallCaps RHY 10 months ago
ASX Health Stocks: Rhythym Bio skyrockets 70pc after being granted UK CA Mark

Rhythm Biosciences surged 70pc this morning after being granted the UK CA Mark for ColoSTAT Anteris Tech was issued another patent in the US Immutep reported positive Phase 2 results   It’s a big day for medical diagnostics company Rhythm...

Stockhead RHY 10 months ago
Top 10 at 10: Which ASX lithium, copper and biotech stocks are hitting warp speed on Wednesday?

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead RHY 10 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead RHY 10 months ago
ASX Health Stocks: Control Bionics launches world’s first autonomous driving wheelchair, DROVE

Control Bionics launched the world’s first autonomous driving wheelchair, DROVE Anteris Technologies to develop an innovative heart valve repair device. Rhythym Bio CEO resigns   Control Bionics (ASX:CBL) will today launch the world’s fir...

Stockhead RHY 11 months ago
ASX Health Stocks: Noxopharm plunges 45pc after discontinuing Veyonda clinical trials

Noxopharm plunged 45pc after scaling down its Veyonda program Rhythm Biosciences rose 25pc after saying that ColoSTAT will be presented at a prestigious gathering Immuron surged 24% as global sales rose significantly   Noxopharm (ASX:NOX)...

Stockhead RHY 11 months ago
Guess which ASX All Ords share just crashed 52% on a TGA update

The Rhythm Biosciences Ltd (ASX: RHY) share price had a day to forget on Monday. The medical diagnostics technology’s shares returned from a trading halt and crashed as much as 52% to 46 cents. The ASX All Ords share ultimately recovered...

Motley Fool RHY 1 year ago
CLOSING BELL: ‘How to falter at the last furlong and limp home like a beaten favourite’, by the ASX

RooLife is today’s ASX winner after getting its drinks into China’s massive Freshippo market The Benchmark climbed early but sagged like a horrid old balloon to end the day around +0.5% Harris tells Credit Suisse “it’s not us, it’s you” an...

Stockhead RHY 1 year ago
Rhythm Biosciences (ASX:RHY) withdraws TGA application for ColoSTAT

Cancer diagnostics technology company Rhythm Biosciences (RHY) withdraws its TGA application for its ColoSTAT technology The withdrawal comes after the company received feedback from the TGA and concluded it wouldn’t be able to answer al...

themarketherald.com.au RHY 1 year ago
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT

Rhythm plunged 45% this morning after announcing some TGA news The FDA has cleared PYC Therapeutics for first ever human trial on Retinitis Pigmentosa Type 11   Rhythm Biosciences (ASX: RHY) crashed 47% this morning after withdrawing its...

Stockhead RHY 1 year ago